Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Drijkoningen

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Gynecologic and Obstetric Investigation|January 1, 1996
Cervical cotinine and macrophage-Langerhans cell density in the normal human uterine cervixW A Poppe, R Peeters, M Drijkoningen, et al.
Journal of Clinical Pathology|June 30, 2009
Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1S Pintens, P Neven, M Drijkoningen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Oncogene|March 18, 2008
Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancyG Eelen, I Vanden Bempt, L Verlinden, et al.
Cancer Investigation|April 9, 2001
Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizesW Landuyt, J Theys, S Nuyts, et al.
Journal of Clinical Pathology|May 27, 2005
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Acta Clinica Belgica|May 13, 2009
Belgian consensus guidelines for follow-up of women with cervical cytological abnormalitiesC A Cuvelier, J P M Bogers, C Bourgain, et al.
Clinical Breast Cancer|March 20, 2002
A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923A Hamilton, D Larsimont, R Paridaens, et al.
The Annals of Thoracic Surgery|September 22, 2009
Open window thoracostomy treatment of empyema is accelerated by vacuum-assisted closureMeindert Palmen, H Nathalie A M van Breugel, Gijs G Geskes, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomasW Landuyt, O Verdoes, D O Darius, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Gynecologic and Obstetric Investigation|January 1, 1996
Cervical cotinine and macrophage-Langerhans cell density in the normal human uterine cervixW A Poppe, R Peeters, M Drijkoningen, et al.
Journal of Clinical Pathology|June 30, 2009
Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1S Pintens, P Neven, M Drijkoningen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Oncogene|March 18, 2008
Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancyG Eelen, I Vanden Bempt, L Verlinden, et al.
Cancer Investigation|April 9, 2001
Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizesW Landuyt, J Theys, S Nuyts, et al.
Journal of Clinical Pathology|May 27, 2005
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Acta Clinica Belgica|May 13, 2009
Belgian consensus guidelines for follow-up of women with cervical cytological abnormalitiesC A Cuvelier, J P M Bogers, C Bourgain, et al.
Clinical Breast Cancer|March 20, 2002
A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923A Hamilton, D Larsimont, R Paridaens, et al.
The Annals of Thoracic Surgery|September 22, 2009
Open window thoracostomy treatment of empyema is accelerated by vacuum-assisted closureMeindert Palmen, H Nathalie A M van Breugel, Gijs G Geskes, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomasW Landuyt, O Verdoes, D O Darius, et al.
Pageof 4